Pharmalot

Pharmalot By Ed Silverman

Biogen to pay $22 million for illegally using charities to pay kickbacks to Medicare patients

Pharmalot By Ed Silverman

Sackler family members deny responsibility for the opioid crisis in a rare public appearance

Pharmalot By Ed Silverman

Former J&J exec sues for sexual discrimination and harassment, alleging ‘ruthless pattern of retaliation’

Pharmalot By Ed Silverman

Pharmalittle: Hospitals grapple with extra dose of Pfizer vaccine; FDA panel meets to review Moderna vaccine

Pharmalot By Ed Silverman

AbbVie wins 21 months of wrinkle-free competition for Botox thanks to an ITC ruling

Pharmalot By Ed Silverman

Opioid prescribing has dropped dramatically since 2011, but experts say there’s ‘more to go’

Pharmalot By Ed Silverman

Pharmalittle: One-quarter of the world won’t have a Covid-19 shot until 2022; naming a Covid vaccine takes time

Pharmalot By Ed Silverman

Pharmalittle: FDA finds Moderna vaccine effective; Trump drug discount card gets new life

Pharmalot By Ed Silverman

State attorneys general urge HHS to penalize drug makers for cutting discounts to hospitals

Pharmalot By Ed Silverman

Sackler family members agree to testify at House hearing on Purdue’s role in opioid crisis

Pharmalot By Ed Silverman

Pharmalittle: FDA’s Hahn insists Pfizer vaccine was authorized as soon as possible; AstraZeneca to pay $39 billion for Alexion

Pharmalot By Ed Silverman

Hospital groups sue HHS for failing to stop drug makers from cutting medication discounts

Pharmalot By Ed Silverman

World Trade council fails to act on proposal to waive IP rights to Covid-19 drugs and vaccines

Pharmalot By Ed Silverman

A historian was cited to support making Purdue a public benefit company. He actually thinks it’s a bad idea

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: FDA panel endorses Pfizer Covid-19 vaccine; meanwhile, Sanofi shot suffers major setback

Pharmalot By Ed Silverman

In a petition, Boehringer warns FDA its definition of ‘strength’ threatens biosimilar competition

Pharmalot By Ed Silverman

Supreme Court upholds controversial Arkansas law that regulates pharmacy benefit managers

Pharmalot By Ed Silverman

Pharmalittle: FDA advisers reviewing Pfizer Covid-19 vaccine today; White House hits roadblock on drug discount cards

Pharmalot By Ed Silverman

Florida finds pharmacy benefit managers are benefiting from a lucrative profit center

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca missteps undermined faith in its Covid-19 vaccine; U.S. jockeys with other countries for Pfizer shot

Pharmalot By Ed Silverman

Federal watchdog urged to investigate the FDA’s handling of Biogen Alzheimer’s drug

Pharmalot By Ed Silverman

Pharmalittle: FDA staff backs Pfizer Covid-19 vaccine; Trump administration failed to lock in larger vaccine supply

Pharmalot By Ed Silverman

Families tell U.N. Vertex is violating human rights with cystic fibrosis drug pricing

Pharmalot By Ed Silverman

FDA finds fault with a Bristol plant, but it may not upset key approval of a cancer drug

Pharmalot By Ed Silverman

Pharmalittle: Biden taps HHS and CDC heads; U.S. taxpayers may get a payback on Gilead’s remdesivir

Pharmalot By Ed Silverman

A payoff for U.S. taxpayers? CDC may have claims on remdesivir patents held by Gilead

Pharmalot By Ed Silverman

FTC says the number of pay-to-delay cases remains low, but vows to keep watch

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings